PETER SHALIT: Open Payments
NPI 1831181700 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$186,665 in 236 payments from 14 companies in 2025. Trend: 2023 $186,007 · 2024 $136,756 · 2025 $186,665
Speaker / faculty: $130,838Travel & lodging: $35,057Consulting: $13,890Food & beverage: $6,881
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 125 | $95,504 |
| Gilead Sciences, Inc. | 60 | $52,388 |
| EMD Serono, Inc. | 23 | $31,033 |
| Merck Sharp & Dohme LLC | 11 | $7,327 |
| Lilly USA, LLC | 3 | $78 |
| Novo Nordisk Inc | 2 | $55 |
| Exact Sciences Corporation | 2 | $53 |
| PFIZER INC. | 2 | $50 |
| Hologic Sales and Service, LLC | 2 | $42 |
| Paratek Pharmaceuticals, Inc. | 2 | $37 |
Products named: CABENUVA, Serostim, APRETUDE, Biktarvy, Yeztugo, Descovy, Sunlenca, DOVATO.
Industry payments across WA — which companies pay providers there.
